Global Transcatheter Mitral Valve Replacement Market 2016-2020
SKU ID :TNV-10292844 | Published Date: 19-Jul-2016 | No. of pages: 46Description
TOC
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Transfemoral implantation
• Transapical implantation
PART 07: Reimbursement and economics of transcatheter mitral valve replacement in US
• Reimbursement for transcatheter mitral valve replacement
• Economic impact of transcatheter mitral valve replacement
PART 08: Geographical segmentation
• Transcatheter mitral valve replacement market in Americas
• Transcatheter mitral valve replacement market in EMEA
• Transcatheter mitral valve replacement market in APAC
PART 09: Market drivers
• Prevalence of mitral regurgitation
• Use of minimally invasive procedures
• Use of transcatheter mitral valve replacement in high-risk individuals
PART 10: Impact of drivers
PART 11: Market challenges
• Availability of alternative treatment
• Stringent regulatory framework
• Lack of skilled personnel
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Development of novel products
• Increase in M&A
• Focus on US
PART 14: Vendor landscape
• Competitive scenario
• Product portfolio matrix
PART 15: Key vendor analysis
• Abbott Laboratories
• Edwards Lifesciences
• Micro Interventional Devices
• Neovasc
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global transcatheter mitral valve replacement market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global transcatheter mitral valve replacement market segmentation by product
Exhibit 05: Comparison of transfemoral and transapical implantation
Exhibit 06: Global transcatheter mitral valve replacement market segmentation by geography 2015
Exhibit 07: Global transcatheter mitral valve replacement market segmentation by geography 2020
Exhibit 08: Global transcatheter mitral valve replacement market segmentation by geography 2015-2020
Exhibit 09: Transcatheter mitral valve replacement market in Americas 2015-2020 ($ millions)
Exhibit 10: Transcatheter mitral valve replacement market in EMEA 2015-2020 ($ millions)
Exhibit 11: Transcatheter mitral valve replacement market in APAC 2015-2020 ($ millions)
Exhibit 12: Impact of drivers
Exhibit 13: Impact of drivers and challenges
Exhibit 14: Major acquisitions 2015
Exhibit 15: Products of few vendors 2015
Exhibit 16: Abbott Laboratories: Key takeaways
Exhibit 17: Edwards Lifesciences: Business segmentation by revenue 2014
Exhibit 18: Edwards Lifesciences: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 19: Edwards Lifesciences: Key takeaways
Exhibit 20: Micro Interventional Devices: Key takeaways
Exhibit 21: Neovasc: Geographical segmentation by revenue 2014
Exhibit 22: Neovasc: Key takeaways
Exhibit 23: Other vendors
Exhibit 24: Emerging vendors
Tables & Figures
Companies
Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices, Neovasc, MitrAssist, NaviGate Cardiac Structures, Valtech.
- PRICE
-
$2500$4000